医改背景下我院门诊近几年心血管系统用药使用情况及变化趋势分析

Analysis on the Use of Cardiovascular System Drugs and its Change Trend in Our Outpatient Department in Recent Years Under the Background of Medical Reform

目的分析医改背景下我院门诊2019—2021年心血管系统用药使用情况及变化趋势。方法本研究选取本院心血管内科在2019年1月至2021年12月门诊使用的心血管系统药物,调查3年中该类药品销售金额及占比、品种变化、各亚类药品销售金额及占比、销售金额前10药品排序情况。结果本次调查3年中门诊心血管系统药物销售金额及占比分别是2019年为128.9001万元(占比8.18%),2020年为118.8521万元(占比9.01%),2021年为117.0574万元(占比9.34%),发现2019—2021年门诊心血管用药销售金额呈下降趋势,而销售金额占比却呈上升趋势;2019—2021年门诊心血管用药种类分别为34种、40种、47种,呈逐年增加趋势;3年中各亚类药品销售金额前3名为抗高血压药、调脂及抗动脉粥样硬化药、抗心律失常药,合计年度销售金额均超过该类药品销售金额90%;该类用药销售金额排前10名的药物3年中均为抗高血压药居多,以CCB类、RASS类为主,同时抗高血压药复方制剂品种也逐步进入前10名排序。整体而言,多数抗高血压药、调脂及抗动脉粥样硬化药呈降价而未减量的现象,多数药物呈DDDs增加、DDDc下降情况。结论医改背景下,我院门诊心血管系统用药结构不断趋于合理、完善,在保证患者用药安全有效的前提下,不断降低患者用药经济负担,提高用药经济性。

Objective To analyze the use of cardiovascular system drugs in our outpatient department from 2019 to 2021 under the background of medical reform and the trend of change.Methods This study selected the cardiovascular system drugs used in the outpatient department of the cardiovascular department of our hospital from January 2019 to December 2021,and investigated the sales amount and proportion,variety change,sales amount and proportion of each subclass of drugs,and the ranking of the top 10 drugs in sales amount in three years.Results The sales amount and proportion of outpatient cardiovascular system drugs in the three years of this survey were 1.289001 million yuan(8.18%)in 2019,1.188521 million yuan(9.01%)in 2020 and 1.170574 million yuan(9.34%)in 2021.It was found that the sales amount of outpatient cardiovascular drugs showed a downward trend from 2019 to 2021,while the proportion of sales amount showed an upward trend.From 2019 to 2021,there were 34,40 and 47 kinds of cardiovascular drugs used in outpatient clinics,showing an increasing trend year by year.In the three years,the top three sales amount of each subcategory of drugs were antihypertensive drugs,lipid regulating and anti atherosclerotic drugs,and antiarrhythmic drugs,and the total annual sales amount exceeded 90%of the sales amount of such drugs.In the three years,the top 10 drugs in terms of sales amount of such drugs were mostly antihypertensive drugs,mainly CCB and RASS.Meanwhile,the varieties of antihypertensive compound preparations gradually entered the top 10.On the whole,most antihypertensive drugs,lipid regulating drugs and antiatherosclerotic drugs decrease in price but not in quantity.Most drugs show an increase in DDDs and a decrease in DDDc.Conclusion Under the background of medical reform,the drug use structure of cardiovascular system in the outpatient department of our hospital tends to be more reasonable and perfect.Under the premise of ensuring the safety and effectiveness of patients'drug use,the economic burden of patients'drug use is constantly reduced and the economic efficiency of drug use is improved.